Emerging therapies in dyslipidaemias
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Molecular Medicine,Physiology
Reference21 articles.
1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017
2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2020
3. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients;Nissen;N. Engl. J. Med.,2023
4. Bempedoic acid: a contemporary review of its pharmacology, efficacy, and safety profile, including recent data from the CLEAR outcomes clinical trial;Park;Curr. Cardiol. Rep.,2023
5. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy;Ballantyne;Eur. J. Prev. Cardiol.,2020
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-05-15
2. The 10 essential questions regarding lipoprotein(a);Current Opinion in Clinical Nutrition & Metabolic Care;2023-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3